Predictors of habitual snoring and obstructive sleep apnea risk in patients with asthma

• Published in: Chest Vol. 135; no. 5; p. 1125
• Main Authors: Teodorescu, Mihaela, Consens, Flavia B, Bria, William F, Coffey, Michael J, McMorris, Marc S, Weatherwax, Kevin J, Palmisano, John, Senger, Carolyn M, Ye, Yining, Kalbfleisch, Jack D, Chervin, Ronald D
• Format: Journal Article
• Language: English
• Published: United States 01.05.2009
• Subjects: Administration, Inhalation; Adolescent; Adrenal Cortex Hormones - administration & dosage; Adult; Aged; Body Mass Index; Body Weight; Comorbidity; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Gastroesophageal Reflux - epidemiology; Gastroesophageal Reflux - physiopathology; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Obesity - epidemiology; Prevalence; Risk Factors; Severity of Illness Index; Sleep Apnea, Obstructive - epidemiology; Sleep Apnea, Obstructive - physiopathology; Snoring - epidemiology; Snoring - physiopathology; Surveys and Questionnaires; Young Adult
• DOI: 10.1378/chest.08-1273

A high prevalence of obstructive sleep apnea (OSA) symptoms was reported in patients with asthma. Our goal was to evaluate factors associated with habitual snoring and OSA risk in these patients. Patients with asthma were surveyed at specialty clinics with the Sleep Apnea scale of the Sleep Disorders Questionnaire (SA-SDQ) and questions about the frequency of asthma symptoms (National Asthma Education and Prevention Program guidelines), followed by medical record review. SA-SDQ scores >or= 36 for men and >or= 32 for women defined high OSA risk. Logistic regression was used to model associations with habitual snoring and high OSA risk. Among 244 patients, 37% snored habitually and 40% demonstrated high OSA risk. Independent predictors of habitual snoring included gastroesophageal reflux disease (GERD) [odds ratio (OR), 2.19; 95% confidence interval (CI), 1.19 to 4.02] and use of an inhaled corticosteroid (ICS) [OR, 2.66; 95% CI, 1.05 to 6.72]. High OSA risk was predicted by asthma severity step (OR, 1.59; 95% CI, 1.23 to 2.06), GERD (OR, 2.70; 95% CI, 1.51 to 4.83), and ICS use (OR, 4.05; 95% CI, 1.56 to 10.53). Linear, dose-dependent relationships of ICS with habitual snoring and high OSA risk were seen (p = 0.004 and p = 0.0006, respectively). Women demonstrated a 2.11 times greater odds for high OSA risk (95% CI, 1.10 to 4.09) when controlling for the above covariates. Symptoms of OSA in patients with asthma are predicted by asthma severity, coexistent GERD, and use of an ICS in a dose-dependent fashion. The well-recognized male gender predominance for OSA symptoms is not apparent in these patients. Further exploration of these relationships may help to explain the increased prevalence of OSA in asthma and provide new insights into the reported female predominance of asthma morbidity.